Pathstone Holdings’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.9K | Sell |
10,000
-1,000
| -9% | -$3.09K | ﹤0.01% | 2145 |
|
|
2025
Q1 | $38.4K | Sell |
11,000
-88
| -0.8% | -$307 | ﹤0.01% | 2177 |
|
|
2024
Q4 | $36.3K | Sell |
11,088
-162
| -1% | -$530 | ﹤0.01% | 2276 |
|
|
2024
Q3 | $43.3K | Buy |
11,250
+593
| +6% | +$2.28K | ﹤0.01% | 2289 |
|
|
2024
Q2 | $32.9K | Buy |
10,657
+502
| +5% | +$1.55K | ﹤0.01% | 2272 |
|
|
2024
Q1 | $26.2K | Hold |
10,155
| – | – | ﹤0.01% | 2267 |
|
|
2023
Q4 | $25.4K | Buy |
+10,155
| New | +$25.4K | ﹤0.01% | 2182 |
|